Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour versus 24-hour postpartum magnesium sulphate for prevention of postpartum eclampsia in severe preeclampsia
PACTR202401609294319Completed
- Sponsor
- University of Ilorin Teaching Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium sulfate in preeclampsia (2 arms), sponsored by University of Ilorin Teaching Hospital. Primary endpoint: Occurrence of eclampsia during or after completion of the assigned magnesium sulphate regimen. Started Feb 2023; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202401609294319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401609294319.